Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-07-22
1996-04-23
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514423, 548518, 548528, 548537, A61K 3140, C07D20706
Patent
active
055103693
ABSTRACT:
Compounds of the invention have the following structure: ##STR1## for example ##STR2## These compounds inhibit thrombin and associated thrombosis.
REFERENCES:
Balasubramanian, et al. J. Med. Chem. Mar. 1993, 36, No. 2, pp. 300-303.
Shuman et al. J. Med. Chem. (8) 1993, 36, No. 3, pp. 314-319.
Kettner et al. The Journal of Biol. Chem., vol. 265, No. 30, Issue of 10/25; pp. 18289-18297 Oct. 1990.
J. Biol. Chemistry, Platelet Glycocalicin vol. 263, No. 10, pp. 3435-3443, T. Okumura et al. May 1978.
J. of Biol. Chem., The Binding of Thrombin to the Surface of Human Platelets, vol. 249, No. 8 pp. 2646-2651, Apr. 1974, Tollefsen et al.
Cell., Molecular Cloning of a Functional Thrombin . . . , vol. 64, pp. 1057-1068, Mar. 22, 1991, Thien-Khai H. Vu et al.
J. of Biol. Chemistry, Thrombin Interaction with Platelets, vol. 262, No. 7 pp. 3030-3036, Mar. (1987), Gronke et al.
J. of Biol. Chem., Structure-Function Relations in the Interaction of alpha-Thrombin with Blood Platelets, vol. 252, No. 20, 7118-7123 Oct. (1977), Workman et al.
Biochemical & Biophysical Research Commun., Minimal Sequence Requirement of Thrombin Receptor Agonist Peptide, vol. 184, No. 2 pp. 790-796 Apr. (1992), Kwan Y. Hui et al.
J. of Biol. Chem., Communication, vol. 267, No. 19, Jul. 1992, pp. 13146-13149, Scarborough et al.
J. of Biol. Chem., Structure-Function Relationships in the Activation of Platelet Thrombin Receptors by Receptor-derived Peptides*, vol. 267, No. 9, pp. 6081-6085 Mar. 1992, Vassallo et al.
Organic & Medicinal Chemistry Letters, alpha-Hydroxy- and alpha-Ketoester Functionalized Thrombin Inhibitors, vol. 2, No. 12, pp. 1607-1612, Iwanowicz et al. (8) 1992.
J. Am. Chem. Soc., Design, Synthesis and Kinetic Evaluation of a Unique Cladd of Elastase Inhibitors . . . , 114, 1854-1863, Edwards et al. (8) 1992.
Thrombos, Diathes, haemorrh. (Stuttg.), Thrombin Interaction with Human Platelets (8) 1974, 32, 207, David R. Phillips.
Chapter 3, Dept. of Biochemistry, St. Jude Children's Research Hospital, Platelet membrane proteins:composition and receptor function, Berndt and Phillips (8) 1981.
Biochemistry, Platelet Stimulation by Thrombin and Other Proteases, vol. 14, No. 6, (8) 1975, Martin et al.
Blood, PPack-Thrombin Inhibits Thrombin-Induced Platelet Aggregation . . . vol. 75, No. 10 May 1990, pp. 1983-1990, Greco et al.
The Embo Journal, The refined 1.9 A crystal structure of human alpha-thrombin . . . , vol. 8, No. 11 pp. 3467-3475, Bode et al. (8) 1989.
Tips vol. 14, Oct. 1993 Tapparelli et al.
Peptides, vol. 12, pp. 1153-1154, Anticoagulant Activity of a Peptide Boronic . . . Hussain et al. (8) 1991.
Brady Stephen F.
Feng Dong-Mei
Freidinger Roger M.
Lumma William C.
Lyle Terry A.
Merck & Co. , Inc.
Parr Richard S.
Richter Johann
Stockton Laura L.
Winokur Melvin
LandOfFree
Pyrrolidine thrombin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolidine thrombin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolidine thrombin inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2308762